<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK99167" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK99167/" /><meta name="ncbi_pagename" content="POLR3-Related Leukodystrophy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>POLR3-Related Leukodystrophy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="POLR3-Related Leukodystrophy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/05/11" /><meta name="citation_author" content="Geneviève Bernard" /><meta name="citation_author" content="Adeline Vanderver" /><meta name="citation_pmid" content="22855961" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK99167/" /><meta name="citation_keywords" content="4H Leukodystrophy" /><meta name="citation_keywords" content="4H Leukodystrophy" /><meta name="citation_keywords" content="DNA-directed RNA polymerase III subunit RPC1" /><meta name="citation_keywords" content="DNA-directed RNA polymerase III subunit RPC2" /><meta name="citation_keywords" content="DNA-directed RNA polymerases I and III subunit RPAC1" /><meta name="citation_keywords" content="POLR1C" /><meta name="citation_keywords" content="POLR3A" /><meta name="citation_keywords" content="POLR3B" /><meta name="citation_keywords" content="POLR3-Related Leukodystrophy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="POLR3-Related Leukodystrophy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Geneviève Bernard" /><meta name="DC.Contributor" content="Adeline Vanderver" /><meta name="DC.Date" content="2017/05/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK99167/" /><meta name="description" content="POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings:" /><meta name="og:title" content="POLR3-Related Leukodystrophy" /><meta name="og:type" content="book" /><meta name="og:description" content="POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK99167/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/pol3-leuk/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK99167/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BA2BEDFC886E100000000059A0274.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK99167_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK99167_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/alpers/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ppp2r5d-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK99167_"><span class="title" itemprop="name">POLR3-Related Leukodystrophy</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: 4H Leukodystrophy</div><p class="contrib-group"><span itemprop="author">Genevi&#x000e8;ve Bernard</span>, MD, MSc, FRCPc and <span itemprop="author">Adeline Vanderver</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK99167_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK99167_ai__"><div class="contrib half_rhythm"><span itemprop="author">Genevi&#x000e8;ve Bernard</span>, MD, MSc, FRCPc<div class="affiliation small">Departments of Neurology and Neurosurgery and Pediatrics, McGill University<br />Department of Medical Genetics, McGill University Health Center<br />Child Health and Human Development Program, Research Institute of the McGill University Health Center<br />Montreal, Quebec, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.lligcm@dranreb.eveiveneg" class="oemail">ac.lligcm@dranreb.eveiveneg</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Adeline Vanderver</span>, MD<div class="affiliation small">Division of Neurology<br />Children&#x02019;s Research Institute<br />Children&#x02019;s Hospital of Philadelphia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@arevrednav" class="oemail">ude.pohc.liame@arevrednav</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 2, 2012</span>; Last Update: <span itemprop="dateModified">May 11, 2017</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="pol3-leuk.Summary" itemprop="description"><h2 id="_pol3-leuk_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings:</p><ul><li class="half_rhythm"><div>Neurologic dysfunction, typically predominated by motor dysfunction (progressive cerebellar dysfunction, and to a lesser extent extrapyramidal [i.e., dystonia], pyramidal [i.e., spasticity] and cognitive dysfunctions)</div></li><li class="half_rhythm"><div>Abnormal dentition (delayed dentition, hypodontia, oligodontia, and abnormally placed or shaped teeth)</div></li><li class="half_rhythm"><div>Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty</div></li><li class="half_rhythm"><div>Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe</div></li></ul><p>POLR3-related leukodystrophy and 4H leukodystrophy are the two recognized terms for five previously described overlapping clinical phenotypes (initially described as distinct entities before their molecular basis was known). These include:</p><ul><li class="half_rhythm"><div>Hypomyelination, hypodontia, hypogonadotropic hypogonadism (4H syndrome);</div></li><li class="half_rhythm"><div>Ataxia, delayed dentition, and hypomyelination (ADDH);</div></li><li class="half_rhythm"><div>Tremor-ataxia with central hypomyelination (TACH);</div></li><li class="half_rhythm"><div>Leukodystrophy with oligodontia (LO);</div></li><li class="half_rhythm"><div>Hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC).</div></li></ul><p>Age of onset is typically in early childhood but later-onset cases have also been reported.</p><p>An infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have pathogenic variants in <i>POLR3A</i> on <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other individuals with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>POLR3-related leukodystrophy is diagnosed by the combination of classic clinical findings, typical brain MRI features, and the presence of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>POLR3A</i>, <i>POLR3B,</i> or <i>POLR1C</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Individualized care by a multidisciplinary team including a pediatric neurologist, clinical geneticist, physiotherapist, occupational therapist, speech and language pathologist, neuropsychologist, rehabilitation physician, dentist, endocrinologist, ophthalmologist, ear-nose-and-throat specialist, and primary care physician is recommended. Special caution needs to be taken when managing dysphagia in this disorder as it is known to vary widely, even in a single day. Swallowing difficulties will progress over time and dystonia should be monitored and treated to prevent complications and improve the quality of life.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>POLR3-related leukodystrophy is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if both pathogenic variants in the family are known.</p></div></div><div id="pol3-leuk.Diagnosis"><h2 id="_pol3-leuk_Diagnosis_">Diagnosis</h2><div id="pol3-leuk.Suggestive_Findings"><h3>Suggestive Findings</h3><p>POLR3-related leukodystrophy <b>should be suspected</b> in individuals with the following major/shared <b>clinical features</b>, which may or may not be present:</p><ul><li class="half_rhythm"><div>Neurologic dysfunction: progressive cerebellar features, including:</div><ul><li class="half_rhythm"><div>Gait ataxia, dysarthria, dysmetria, tremor, eye movement abnormalities; and</div></li><li class="half_rhythm"><div>To a lesser extent, extrapyramidal (typically dystonia), pyramidal, and cognitive features</div></li></ul></li><li class="half_rhythm"><div>Abnormal dentition (e.g., hypodontia, oligodontia, delayed teeth eruption) [<a class="bk_pop" href="#pol3-leuk.REF.wolff.2010.386">Wolff et al 2010</a>]</div></li><li class="half_rhythm"><div>Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty</div></li><li class="half_rhythm"><div>Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe</div></li></ul><p>Note: Although this tetrad is highly suggestive of the diagnosis, not all features are present in all individuals who have POLR3-related leukodystrophy.</p><p><b>Brain MRI findings</b></p><ul><li class="half_rhythm"><div>A hypomyelinating leukodystrophy pattern characterized by T<sub>2</sub> mild hyperintensity of the white matter and T<sub>1</sub> hyperintensity, isointensity, or mild hypointensity of the white matter when compared with grey matter structures [<a class="bk_pop" href="#pol3-leuk.REF.schiffmann.2009.750">Schiffmann &#x00026; van der Knaap 2009</a>]</div></li><li class="half_rhythm"><div>Relative preservation of myelination of specific brain structures, i.e. T<sub>2</sub> hypointense signal (normal or almost normal white matter signal) of the dentate nuclei, anterolateral nuclei of the thalami, globi pallidi, pyramidal tracts in the posterior limbs of the internal capsules, and optic radiations [<a class="bk_pop" href="#pol3-leuk.REF.steenweg.2010.2971">Steenweg et al 2010</a>, <a class="bk_pop" href="#pol3-leuk.REF.la_piana.2014.214">La Piana et al 2014</a>, <a class="bk_pop" href="#pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</a>]</div></li><li class="half_rhythm"><div>Variably present: cerebellar atrophy and thinning of the corpus callosum [<a class="bk_pop" href="#pol3-leuk.REF.la_piana.2014.214">La Piana et al 2014</a>, <a class="bk_pop" href="#pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</a>]</div></li><li class="half_rhythm"><div>Rarely, an atypical MRI pattern with either</div><ul><li class="half_rhythm"><div>Selective hypomyelination of the corticospinal tracts; or</div></li><li class="half_rhythm"><div>Cerebellar atrophy with or without focal hypomyelination [<a class="bk_pop" href="#pol3-leuk.REF.la_piana.2016.1622">La Piana et al 2016</a>]; or</div></li><li class="half_rhythm"><div>Involvement of the striata and red nuclei [<a class="bk_pop" href="#pol3-leuk.REF.azmanov.2016.4302">Azmanov et al 2016</a>]</div></li></ul></li></ul><p>See <a class="figpopup" href="/books/NBK99167/figure/pol3-leuk.F1/?report=objectonly" target="object" rid-figpopup="figpol3leukF1" rid-ob="figobpol3leukF1">Figure 1</a>.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figpol3leukF1" co-legend-rid="figlgndpol3leukF1"><a href="/books/NBK99167/figure/pol3-leuk.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figpol3leukF1" rid-ob="figobpol3leukF1"><img class="small-thumb" src="/books/NBK99167/bin/pol3-leuk-Image001.gif" src-large="/books/NBK99167/bin/pol3-leuk-Image001.jpg" alt="Figure 1. . MRI of the brain of an individual with molecularly confirmed 4H syndrome A." /></a><div class="icnblk_cntnt" id="figlgndpol3leukF1"><h4 id="pol3-leuk.F1"><a href="/books/NBK99167/figure/pol3-leuk.F1/?report=objectonly" target="object" rid-ob="figobpol3leukF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">MRI of the brain of an individual with molecularly confirmed 4H syndrome A. Sagittal T<sub>1</sub>-weighted image (midline) showing cerebellar atrophy (arrowhead) as well as a thin corpus callosum (arrow). B. Axial T<sub>2</sub>-weighted image of the brain at the level of <a href="/books/NBK99167/figure/pol3-leuk.F1/?report=objectonly" target="object" rid-ob="figobpol3leukF1">(more...)</a></p></div></div></div><div id="pol3-leuk.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of POLR3-related leukodystrophy <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the combination of classic clinical findings, typical brain MRI features, and the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>POLR3A</i>, <i>POLR3B</i>, or <i>POLR1C</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK99167/table/pol3-leuk.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figpol3leukTmoleculargenetictestingus" rid-ob="figobpol3leukTmoleculargenetictestingus">Table 1</a>).</p><p>Molecular testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> The order of genes to be tested depends on ancestry of the individual:</p><ul><li class="half_rhythm"><div>In French-Canadian individuals, sequencing of <i>POLR3A</i> should be performed first and followed by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div><ul><li class="half_rhythm"><div>If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, sequencing of <i>POLR3B</i> is performed, followed by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no pathogenic variant is found.</div></li></ul></li><li class="half_rhythm"><div>For individuals of European ancestry sequencing of <i>POLR3B</i> should be performed first.</div><ul><li class="half_rhythm"><div>If a single variant is detected, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of <i>POLR3B</i> is done.</div></li><li class="half_rhythm"><div>If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, sequencing of <i>POLR3A</i> is performed, followed by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no pathogenic variant is found.</div></li></ul></li><li class="half_rhythm"><div>For individuals from the non-French-Canadian and non-European ancestry, sequencing can start with either <i>POLR3A</i> or <i>POLR3B</i>, followed by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li></ul><p><i>POLR1C</i> is tested when sequencing and <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of <i>POLR3A</i> and <i>POLR3B</i> are both negative.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>POLR3A</i>, <i>POLR3B</i>, <i>POLR1C</i> with or without other genes of interest (see <a href="#pol3-leuk.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included and the <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of multigene panels vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting identification of pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing based tests.</p><p>For more information on multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation). For more information on comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>.</p><div id="pol3-leuk.T.molecular_genetic_testing_us" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in POLR3-Related Leukodystrophy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK99167/table/pol3-leuk.T.molecular_genetic_testing_us/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pol3-leuk.T.molecular_genetic_testing_us_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of POLR3-Related Leukodystrophy Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detected by Test Method</th></tr><tr><th headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3" id="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></th><th headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3" id="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></th></tr></thead><tbody><tr><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POLR3A</i></td><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">41%&#x000a0;<sup>5,&#x000a0;6</sup></td><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%&#x000a0;<sup>5,&#x000a0;6</sup></td><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POLR3B</i></td><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">49%&#x000a0;<sup>5,&#x000a0;8</sup></td><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~97%&#x000a0;<sup>5,&#x000a0;8</sup></td><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~3%&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POLR1C</i></td><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%&#x000a0;<sup>10</sup></td><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%&#x000a0;<sup>10</sup></td><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%</td><td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_1 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="pol3-leuk.TF.1.1"><p class="no_margin">See <a href="/books/NBK99167/#pol3-leuk.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="pol3-leuk.TF.1.2"><p class="no_margin">See <a href="#pol3-leuk.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="pol3-leuk.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="pol3-leuk.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="pol3-leuk.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#pol3-leuk.REF.daoud.2013.194">Daoud et al [2013]</a>, <a class="bk_pop" href="#pol3-leuk.REF.takanashi.2014.259">Takanashi et al [2014]</a>, <a class="bk_pop" href="#pol3-leuk.REF.wolf.2014.1898">Wolf et al [2014]</a>, <a class="bk_pop" href="#pol3-leuk.REF.la_piana.2016.1622">La Piana et al [2016]</a></p></div></dd><dt>6. </dt><dd><div id="pol3-leuk.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#pol3-leuk.REF.bernard.2011.415">Bernard et al [2011]</a>, <a class="bk_pop" href="#pol3-leuk.REF.shimojima.2014.315">Shimojima et al [2014]</a>, <a class="bk_pop" href="#pol3-leuk.REF.potic.2015.22">Potic et al [2015]</a></p></div></dd><dt>7. </dt><dd><div id="pol3-leuk.TF.1.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>8. </dt><dd><div id="pol3-leuk.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#pol3-leuk.REF.gutierrez.2015.69">Gutierrez et al [2015]</a>, <a class="bk_pop" href="#pol3-leuk.REF.jurkiewicz.2017.213">Jurkiewicz et al [2017]</a></p></div></dd><dt>9. </dt><dd><div id="pol3-leuk.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#pol3-leuk.REF.gutierrez.2015.69">Gutierrez et al [2015]</a></p></div></dd><dt>10. </dt><dd><div id="pol3-leuk.TF.1.10"><p class="no_margin"><a class="bk_pop" href="#pol3-leuk.REF.thiffault.2015.7623">Thiffault et al [2015]</a></p></div></dd></dl></div></div></div></div></div><div id="pol3-leuk.Clinical_Characteristics"><h2 id="_pol3-leuk_Clinical_Characteristics_">Clinical Characteristics</h2><div id="pol3-leuk.Clinical_Description"><h3>Clinical Description</h3><p>POLR3-related leukodystrophy is a hypomyelinating leukodystrophy characterized by neurologic (cerebellar, extrapyramidal, pyramidal, and cognitive) and non-neurologic (dental, endocrine, and ocular) features.</p><p>Before the identification of the involved genes, five overlapping clinical phenotypes were described and are now all recognized as part of the spectrum of POLR3-related leukodystrophy:</p><ul><li class="half_rhythm"><div><b>4H syndrome.</b>
<i>H</i>ypomyelination, <i>h</i>ypodontia, <i>h</i>ypogonadotropic <i>h</i>ypogonadism [<a class="bk_pop" href="#pol3-leuk.REF.wolf.2005.1461">Wolf et al 2005</a>, <a class="bk_pop" href="#pol3-leuk.REF.timmons.2006.2066">Timmons et al 2006</a>, <a class="bk_pop" href="#pol3-leuk.REF.v_zquezl_pez.2008.204">V&#x000e1;zquez-L&#x000f3;pez et al 2008</a>]</div></li><li class="half_rhythm"><div><b>ADDH.</b>
<i>A</i>taxia, <i>d</i>elayed <i>d</i>entition, and <i>h</i>ypomyelination [<a class="bk_pop" href="#pol3-leuk.REF.wolf.2007.64">Wolf et al 2007</a>, <a class="bk_pop" href="#pol3-leuk.REF.wolff.2010.386">Wolff et al 2010</a>]</div></li><li class="half_rhythm"><div><b>TACH.</b>
<i>T</i>remor-<i>a</i>taxia with <i>c</i>entral <i>h</i>ypomyelination [<a class="bk_pop" href="#pol3-leuk.REF.bernard.2010.457">Bernard et al 2010</a>, <a class="bk_pop" href="#pol3-leuk.REF.bernard.2011.415">Bernard et al 2011</a>, <a class="bk_pop" href="#pol3-leuk.REF.t_treault.2011.652">T&#x000e9;treault et al 2011</a>, <a class="bk_pop" href="#pol3-leuk.REF.t_treault.2012.122">T&#x000e9;treault et al 2012</a>]</div></li><li class="half_rhythm"><div><b>LO.</b>
<i>L</i>eukodystrophy with <i>o</i>ligodontia [<a class="bk_pop" href="#pol3-leuk.REF.atrouni.2003.76">Atrouni et al 2003</a>, <a class="bk_pop" href="#pol3-leuk.REF.chouery.2011.73">Chouery et al 2011</a>]</div></li><li class="half_rhythm"><div><b>HCAHC.</b>
<i>H</i>ypomyelination with <i>c</i>erebellar <i>a</i>trophy and <i>h</i>ypoplasia of the <i>c</i>orpus callosum [<a class="bk_pop" href="#pol3-leuk.REF.sasaki.2009.582">Sasaki et al 2009</a>, <a class="bk_pop" href="#pol3-leuk.REF.saitsu.2011.644">Saitsu et al 2011</a>]</div></li></ul><p><b>Age of onset</b> is typically in early childhood but later-onset cases have also been reported.</p><p><b>Neurologic dysfunction</b> includes prominent cerebellar features leading to progressive gait abnormalities, dysmetria, dysdiadochokinesis, dysarthria, and extraocular movement abnormalities including progressive loss of pursuits (saccadic ocular pursuits), abnormal saccades (i.e., hypo- or hypermetric), and gaze-evoked nystagmus. Progressive vertical more than horizontal gaze restriction has also been reported. Hypersalivation and dysphagia are also commonly seen, typically later in the disease course.</p><ul><li class="half_rhythm"><div>Individuals may also develop extrapyramidal features &#x02013; almost always dystonia.</div></li><li class="half_rhythm"><div>Mild pyramidal features are typically present but are not problematic in the vast majority of individuals.</div></li><li class="half_rhythm"><div>An upper-extremity tremor (usually cerebellar in nature) with or without a dystonic component may be a presenting sign.</div></li><li class="half_rhythm"><div>Cognitive decline typically occurs later, except in late-onset cases.</div></li><li class="half_rhythm"><div>Approximately 10% of individuals have later onset and slower progression; they typically present with academic difficulties and cognitive decline which manifests as a plateau in learning at school. Those with later onset may have also behavioral abnormalities.</div></li></ul><p><b>Dental abnormalities</b> include delayed dentition, hypodontia, oligodontia, and eruption of abnormally placed or shaped teeth, among others [<a class="bk_pop" href="#pol3-leuk.REF.wolff.2010.386">Wolff et al 2010</a>]. Dental abnormalities may be subtle and have not been seen in all individuals.</p><p><b>Endocrine abnormalities.</b> Hypogonadotropic hypogonadism (HH), the most typical endocrine characteristic, is note seen in all individuals. When reported, HH typically presents with delayed or arrested puberty or absence of early pubertal changes. Other reported endocrine abnormalities include short stature (in 50% of individuals [<a class="bk_pop" href="#pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</a>]) and growth hormone deficiency [<a class="bk_pop" href="#pol3-leuk.REF.potic.2012.920">Potic et al 2012</a>, <a class="bk_pop" href="#pol3-leuk.REF.billington.2015.314594">Billington et al 2015</a>, <a class="bk_pop" href="#pol3-leuk.REF.potic.2015.22">Potic et al 2015</a>].</p><p><b>Ocular abnormality.</b> Myopia, typically progressive over several years and eventually leading to severe myopia, is the most common non-neurologic feature.</p><p><b>Course and life span.</b> The course of POLR3-related leukodystrophy is invariably progressive. Life span depends on the supportive measures put in place to prevent secondary complications. POLR3-related leukodystrophy is considered to be a life-limiting condition; those with earlier onset are at a higher risk for mortality in young adulthood. Individuals with later onset or with a slower progressive disease course could survive later into adulthood (i.e., 4<sup>th</sup>-5<sup>th</sup> decade).</p><p><b>Additional features</b> seen less frequently include the following [<a class="bk_pop" href="#pol3-leuk.REF.wolf.2005.1461">Wolf et al 2005</a>, <a class="bk_pop" href="#pol3-leuk.REF.timmons.2006.2066">Timmons et al 2006</a>, <a class="bk_pop" href="#pol3-leuk.REF.v_zquezl_pez.2008.204">V&#x000e1;zquez-L&#x000f3;pez et al 2008</a>, <a class="bk_pop" href="#pol3-leuk.REF.bekiesinskafigatowska.2010.574">Bekiesinska-Figatowska et al 2010</a>, <a class="bk_pop" href="#pol3-leuk.REF.orcesi.2010.359">Orcesi et al 2010</a>, <a class="bk_pop" href="#pol3-leuk.REF.wolff.2010.386">Wolff et al 2010</a>, <a class="bk_pop" href="#pol3-leuk.REF.sato.2011.179">Sato et al 2011</a>, <a class="bk_pop" href="#pol3-leuk.REF.potic.2012.920">Potic et al 2012</a>]:</p><ul><li class="half_rhythm"><div><b>Neurologic.</b> Seizures reported in a minority of individuals [<a class="bk_pop" href="#pol3-leuk.REF.bernard.2011.415">Bernard et al 2011</a>, <a class="bk_pop" href="#pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</a>]</div></li><li class="half_rhythm"><div><b>Ocular</b></div><ul><li class="half_rhythm"><div>Optic atrophy</div></li><li class="half_rhythm"><div>Cataracts reported in four individuals [<a class="bk_pop" href="#pol3-leuk.REF.sato.2011.179">Sato et al 2011</a>, <a class="bk_pop" href="#pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</a>]</div></li></ul></li></ul><p><b>Neurophysiologic investigations.</b> All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals undergoing EMG and nerve conduction studies had normal results [Author, personal observation].</p><p><b>Wiedemann-Rautenstrauch syndrome</b> (neonatal progeroid syndrome). A newborn with features of this disorder (including extreme small size, sparse scalp hair, broad abnormally shaped skull, triangular face with midface retraction, natal teeth, decreased subcutaneous fat, and limb contractures) was recently reported to have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> truncating variants in <i>POLR3A</i> on <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> that were predicted to result in little residual POLR3 function. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other patients with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome [<a class="bk_pop" href="#pol3-leuk.REF.jay.2016.3343">Jay et al 2016</a>].</p></div><div id="pol3-leuk.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><b><i>POLR3A</i></b></p><ul><li class="half_rhythm"><div>Individuals with <i>POLR3A</i> pathogenic variants tend to have a later disease onset than those with <i>POLR3B</i> pathogenic variants but more rapid disease progression [<a class="bk_pop" href="#pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</a>].</div></li><li class="half_rhythm"><div>A single female infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> truncating pathogenic variants in <i>POLR3A</i> [<a class="bk_pop" href="#pol3-leuk.REF.jay.2016.3343">Jay et al 2016</a>].</div></li></ul><p><b><i>POLR3B</i></b></p><ul><li class="half_rhythm"><div>Individuals with <i>POLR3B</i> pathogenic variants have earlier disease onset than those with <i>POLR3A</i> pathogenic variants but a slower disease course.</div></li><li class="half_rhythm"><div>Those with <i>POLR3B</i> pathogenic variants are more likely to have cerebellar atrophy on MRI and preservation of the myelination of the corticospinal tracts at the level of the internal capsules, compared to individuals with <i>POLR3A</i> pathogenic variants.</div></li><li class="half_rhythm"><div>The common <i>POLR3B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.1568T&#x0003e;A (p.Val523Glu) is very mild. Indeed, individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for this variant were either asymptomatic or very mildly symptomatic in early adulthood [<a class="bk_pop" href="#pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</a>].</div></li></ul><p><b><i>POLR1C.</i></b> Limited information is available on individuals with <i>POLR1C</i> pathogenic variants.</p></div><div id="pol3-leuk.Prevalence"><h3>Prevalence</h3><p>The prevalence of POLR3-related leukodystrophy is unknown.</p><p>Individuals with POLR3-related leukodystrophy have been identified worldwide [<a class="bk_pop" href="#pol3-leuk.REF.atrouni.2003.76">Atrouni et al 2003</a>, <a class="bk_pop" href="#pol3-leuk.REF.sasaki.2009.582">Sasaki et al 2009</a>, <a class="bk_pop" href="#pol3-leuk.REF.bekiesinskafigatowska.2010.574">Bekiesinska-Figatowska et al 2010</a>, <a class="bk_pop" href="#pol3-leuk.REF.saitsu.2011.644">Saitsu et al 2011</a>, <a class="bk_pop" href="#pol3-leuk.REF.sato.2011.179">Sato et al 2011</a>, <a class="bk_pop" href="#pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</a>].</p></div></div><div id="pol3-leuk.Genetically_Related_Allelic_Di"><h2 id="_pol3-leuk_Genetically_Related_Allelic_Di_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>POLR3A</i> or <i>POLR3B</i>.</p><p>Different <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants <i>POLR1C</i> are associated with <a href="/books/n/gene/tcs/">Treacher Collins syndrome</a>.</p></div><div id="pol3-leuk.Differential_Diagnosis"><h2 id="_pol3-leuk_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of POLR3-related leukodystrophy includes other hypomyelinating leukodystrophies. See <a class="figpopup" href="/books/NBK99167/table/pol3-leuk.T.hypomyelinating_leukodystrop/?report=objectonly" target="object" rid-figpopup="figpol3leukThypomyelinatingleukodystrop" rid-ob="figobpol3leukThypomyelinatingleukodystrop">Table 2</a>.</p><div id="pol3-leuk.T.hypomyelinating_leukodystrop" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Hypomyelinating Leukodystrophies to Consider in the Differential Diagnosis of POLR3-Related Leukodystrophy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK99167/table/pol3-leuk.T.hypomyelinating_leukodystrop/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pol3-leuk.T.hypomyelinating_leukodystrop_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of This Disorder</th></tr><tr><th headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4" id="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/POLR3-related leukodystrophy</th><th headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4" id="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from POLR3-related leukodystrophy</th></tr></thead><tbody><tr><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pmd/"><i>PLP1</i>-related disorders</a></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLP1</i></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Variable age of onset</div></li><li class="half_rhythm"><div>Severe hypomyelination in earlier-onset forms on brain MRI</div></li><li class="half_rhythm"><div>Prominent cerebellar features in severe "connatal" form of <i>PLP1</i>-related disorders</div></li></ul></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Severity ranging from: neonatal presentation w/nystagmus, axial hypotonia evolving into spastic quadraparesis, &#x00026; ataxia (PMD); to an infantile-onset disorder (HEMS); to a later-onset presentation w/spastic paraparesis (SPG2)</div></li><li class="half_rhythm"><div>Typically, prominent spasticity &#x00026; absence of non-neurologic manifestations seen in POLR3-related leukodystrophy</div></li><li class="half_rhythm"><div>In HEMS, individuals present w/infantile-onset nystagmus, gait ataxia, axial hypotonia, &#x00026; dysarthria with or without spasticity. They have a characteristic brain MRI pattern w/mild T<sub>2</sub> hyperintensities of the frontoparietal periventricular white matter, optic radiations, medulla oblongata, caudal pons, subcortical cerebellar white matter, hilus of the dentate nucleus, &#x00026; peridentate white matter. A typical pattern of alternating hyper-/hypo-hyperintense stripes on T<sub>2</sub>-weighted imaging can be seen in the posterior limb of the internal capsule.</div></li><li class="half_rhythm"><div>In later-onset forms (spastic paraparesis), no (or more discrete) abnormalities on brain MRI</div></li></ul></td></tr><tr><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pmld1/">Pelizaeus-Merzbacher-like disease 1</a></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GJC2</i></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Variable age of onset &#x00026; severity</div></li><li class="half_rhythm"><div>More severe disease in those w/early-infantile onset</div></li></ul></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Brain MRI findings similar to those seen in PMD, i.e., diffuse hypomyelination but w/characteristic involvement of the brain stem, in particular the pons</div></li><li class="half_rhythm"><div>Spastic paraparesis designated as SPG44 in those w/later onset</div></li></ul></td></tr><tr><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cockayne/">Classic Cockayne syndrome</a></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ERCC6</i><br /><i>ERCC8</i></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypomyelination</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Typically, early childhood presentation</div></li><li class="half_rhythm"><div>Main non-neurologic clinical features: postnatal growth failure, <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial traits, propensity to cavities, skin hypersensitivity to sunlight</div></li><li class="half_rhythm"><div>Neurologic features typically not seen in POLR3-related leukodystrophy: acquired progressive microcephaly, peripheral neuropathy</div></li><li class="half_rhythm"><div>Delayed myelination (instead of hypomyelination), cerebral atrophy &#x00026; brain calcifications variably seen on MRI</div></li></ul></td></tr><tr><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Trichothiodystrophy&#x000a0;<sup>2</sup><br />(OMIM <a href="http://omim.org/phenotypicSeries/PS601675" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS601675</a>)</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ERCC2</i><br /><i>ERCC3</i><br /><i>GTF2H5</i><br /><i>MPLKIP</i><br /><i>RNF113A</i></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR or XL</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebral hypomyelination w/out prominent cerebral atrophy or basal ganglia calcifications on brain MRI</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variable clinical features including different combinations of:
<ul><li class="half_rhythm"><div>Brittle hair</div></li><li class="half_rhythm"><div>&#x0201c;Tiger tail&#x0201d; appearance of hair on light microscopy</div></li><li class="half_rhythm"><div>Skin hypersensitivity to sun exposure</div></li><li class="half_rhythm"><div>Ichthyosis</div></li><li class="half_rhythm"><div>Infertility</div></li><li class="half_rhythm"><div>Neurologic manifestations that may include intellectual disability, microcephaly, ataxia</div></li></ul></td></tr><tr><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/issd/">Free sialic acid storage disorders</a> (including Salla disease &#x00026; intermediate severe Salla disease; excluding infantile free sialic storage disease)</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC17A5</i></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Early childhood onset</div></li><li class="half_rhythm"><div>Cerebellar features</div></li><li class="half_rhythm"><div>On MRI: hypomyelination w/or w/out thinning of the corpus callosum, cerebellar atrophy</div></li></ul></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Variable severity</div></li><li class="half_rhythm"><div>Progressive facial coarsening</div></li></ul></td></tr><tr><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hypo-mcc/">Hypomyelination and congenital cataract</a></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FAM126A</i></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Diffuse hypomyelination on brain MRI</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Onset typically in infancy w/<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts (variably present) &#x00026; psychomotor regression</div></li><li class="half_rhythm"><div>Peripheral neuropathy present in most individuals</div></li><li class="half_rhythm"><div>Diffuse hypomyelination w/superimposed T<sub>1</sub> hypointensities &#x00026; T<sub>2</sub> hyperintensities on brain MRI; cerebellar hemispheres may show mild high T<sub>2</sub> signal resulting in a blurry grey-white matter junction.</div></li></ul></td></tr><tr><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUBB4A</i>-related leukodystrophy (H-ABC)</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUBB4A</i></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD/DN&#x000a0;<sup>1</sup></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early-onset motor regression and/or delay</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Prominent extrapyramidal features, more specifically dystonia</div></li><li class="half_rhythm"><div>Progressive atrophy of the basal ganglia (specifically the putamen) &#x00026; cerebellum characteristically seen on brain MRI</div></li></ul></td></tr><tr><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18q minus syndrome<br />(OMIM <a href="http://omim.org/entry/601808" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601808</a>)</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MBP</i> (haplo-insufficiency caused by <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at 18q23)</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypomyelination</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Differentiated from other hypomyelinating leukodystrophies by multisystemic findings: dysmorphisms; endocrine, cardiac, immune, &#x00026; musculoskeletal abnormalities</div></li><li class="half_rhythm"><div>2 main white-matter abnormalities on brain MRI: hypomyelination; multifocal T<sub>2</sub> &#x00026; FLAIR hyperintensities</div></li><li class="half_rhythm"><div>Structural brain abnormalities (heterotopias, <i>ex vacuo</i> ventriculomegaly, cerebellar hypoplasia, &#x00026; porencephalic cysts)</div></li></ul></td></tr><tr><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fucosidosis<br />(OMIM <a href="http://omim.org/entry/230000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">230000</a>)</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FUCA1</i></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypomyelination</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Type 1. Differentiated clinically from the other hypomyelinating leukodystrophies by presence of coarse facial features, hepatosplenomegaly, &#x00026; cardiomegaly</div></li><li class="half_rhythm"><div>Type 2. Typically differentiated by presence of mild coarsening, growth retardation, &#x00026; angiokeratoma corporis diffusum</div></li><li class="half_rhythm"><div>On MRI, distinctive hypomyelinating pattern; w/time, atrophy involving both the cerebrum &#x00026; cerebellum, w/hypointensities of the globi pallidi, substantia nigra, &#x00026; thalami</div></li></ul></td></tr><tr><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DARS</i>-related leukodystrophy<br />(OMIM <a href="http://omim.org/entry/615281" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615281</a>)</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DARS</i></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypomyelinating leukodystrophy</div></li><li class="half_rhythm"><div>Cerebellar features</div></li></ul></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Prominent spasticity of the legs</div></li><li class="half_rhythm"><div>Involvement of specific tracts on MRI</div></li></ul></td></tr><tr><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RARS</i>-related leukodystrophy<br />(OMIM <a href="http://omim.org/entry/616140" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616140</a>)</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RARS</i></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypomyelinating leukodystrophy</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Prominent spasticity</td></tr><tr><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Peripheral neuropathy, central hypomyelination, Waardenburg syndrome, Hirschsprung disease (PCWH)<br />(OMIM <a href="http://omim.org/entry/609136" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609136</a>)</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SOX10</i></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Peripheral demyelinating neuropathy (leading to sensory deficits &#x00026; loss of stretch reflexes)</div></li><li class="half_rhythm"><div>Hypomyelinating leukodystrophy (leading to early-onset hypotonia, developmental delay, &#x00026; nystagmus evolving over time into spasticity &#x00026; cerebellar ataxia)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/ws1/">Waardenburg syndrome</a> (manifest as pigmentary abnormalities including heterochromia iridis &#x00026; sensorineural hearing loss)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/hirschsprung-ov/">Hirschsprung disease</a></div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a></p></div></dd><dt></dt><dd><div><p class="no_margin">XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt></dt><dd><div><p class="no_margin">PMD = Pelizaeus-Merzbacher disease</p></div></dd><dt></dt><dd><div><p class="no_margin">HEMS = hypomyelination of early myelinating structures</p></div></dd><dt>1. </dt><dd><div id="pol3-leuk.TF.2.1"><p class="no_margin">DN = <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date have had a <i>de novo</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div></dd></dl></div></div></div></div><div id="pol3-leuk.Management"><h2 id="_pol3-leuk_Management_">Management</h2><div id="pol3-leuk.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with a POLR3-related leukodystrophy, the following are recommended:</p><ul><li class="half_rhythm"><div>Pediatric neurology consultation</div></li><li class="half_rhythm"><div>Swallowing assessment</div></li><li class="half_rhythm"><div>Physiotherapy evaluation</div></li><li class="half_rhythm"><div>Occupational therapy evaluation</div></li><li class="half_rhythm"><div>Speech and language pathology assessment</div></li><li class="half_rhythm"><div>Rehabilitation physician (i.e., physiatrist) consultation</div></li><li class="half_rhythm"><div>Neuropsychology evaluation</div></li><li class="half_rhythm"><div>Brain MRI, if not performed at the time of diagnosis</div></li><li class="half_rhythm"><div>Dentistry consultation</div></li><li class="half_rhythm"><div>Endocrine consultation</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation</div></li><li class="half_rhythm"><div>Ear-nose-and-throat specialist consultation for hypersalivation and swallowing issues</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="pol3-leuk.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Individualized care by a multidisciplinary team including a pediatric neurologist, clinical geneticist, physiotherapist, occupational therapist, speech and language pathologist, neuropsychologist, rehabilitation physician, dentist, endocrinologist, ophthalmologist, ear-nose-and-throat specialist, and primary care physician is recommended.</p><p>Manifestations such as ambulation difficulties and seizures are managed in a routine manner.</p><p>Special caution needs to be taken when managing dysphagia in this disorder as it is known to be quite variable, even in a single day. This is probably due to the prominent cerebellar involvement, leading to more incoordination of swallowing with fatigue, but also with some unpredictability. Dysphagia management is therefore important. Swallowing difficulties will progress over time and individuals may require gastrostomy to manage nutrition.</p><p>Spasticity and dystonia should be monitored and treated to prevent complications and to improve the quality of life.</p><p>Hypersalivation is managed with the multidisciplinary team and an otolaryngologist. Treatment must be individualized. Therapies to consider include rehabilitation (e.g., oromotor therapy, behavioral therapy); medical therapy (e.g., anticholinergic medications, botulinum toxin injections); and, in severe cases, surgery (e.g., relocation of the parotid ducts and relocation of the submandibular ducts with or without sublingual gland excision).</p><p>Learning difficulties are likely to progress slowly. The cognitive involvement is typically much less severe than the motor involvement. In contrast, activities of daily living are likely to become problematic early on in the disease course as motor difficulties make patients progressively more dependent on assistance from others.</p><p>Dental manifestations should be managed, when necessary, by a dentist and/or orthodontist.</p><p>Patients should be followed regularly by an endocrinologist. The decision to treat sex and growth hormone deficiency, when present, should be made on an individual basis.</p><p>Patients need to be followed regularly by an ophthalmologist. A significant proportion of patients will have progressive myopia over several years, which will become severe before stabilizing.</p></div><div id="pol3-leuk.Surveillance"><h3>Surveillance</h3><p>No general surveillance guidelines have been developed to date; monitoring should be individualized.</p></div><div id="pol3-leuk.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid the following:</p><ul><li class="half_rhythm"><div>Foods that are likely to lead to choking</div></li><li class="half_rhythm"><div>Medications acting on D2 receptor blockers (e.g., neuroleptics such as haloperidol or risperidone, anti-nausea medications such as metoclopramide) as these can exacerbate the extrapyramidal features</div></li></ul></div><div id="pol3-leuk.Evaluation_of_Relatives_at_Ris"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#pol3-leuk.Related_Genetic_Counseling_Iss">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="pol3-leuk.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://www.ClinicalTrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>www.ClinicalTrialsRegister.eu</u></a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="pol3-leuk.Genetic_Counseling"><h2 id="_pol3-leuk_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="pol3-leuk.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>POLR3-related leukodystrophy is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="pol3-leuk.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>POLR3A</i>, <i>POLR3B</i>, or <i>POLR1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Note: The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is similar among family members; however, the severity can vary.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with POLR3-related leukodystrophy are obligate heterozygotes (i.e., carriers of one <i>POLR3A</i>, <i>POLR3B</i>, or <i>POLR1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>POLR3A</i>, <i>POLR3B</i>, or <i>POLR1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="pol3-leuk.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>POLR3A</i>, <i>POLR3B</i>, or <i>POLR1C</i> pathogenic variants in the family.</p></div><div id="pol3-leuk.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p><b>Predictive testing</b> for at-risk asymptomatic adult family members requires prior identification of the pathogenic variants in the family. Note: Although the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is similar among family members, the severity and age of onset can vary.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="pol3-leuk.Prenatal_Testing_and_Preimplan"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>POLR3A</i>, <i>POLR3B</i>, or <i>POLR1C</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for POLR3-related leukodystrophy are possible.</p></div></div><div id="pol3-leuk.Resources"><h2 id="_pol3-leuk_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>European Leukodystrophy Association (ELA)</b></div><div>2, rue Mi-les-Vignes</div><div>B.P. 61024</div><div>Laxou Cedex 54521</div><div>France</div><div><b>Phone:</b> 03833093 34</div><div><b>Fax:</b> 03833000 68</div><div><b>Email:</b> ela@ela-asso.com</div><div><a href="http://www.ela-asso.com" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ela-asso.com</a></div></li><li class="half_rhythm"><div><b>Leukodystrophy Australia</b></div><div>P O Box 2550</div><div>Mount Waverley Victoria 3149</div><div>Australia</div><div><b>Phone:</b> 1800-141-400 (toll free)</div><div><b>Email:</b> info@leuko.org.au</div><div><a href="http://www.leuko.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.leuko.org.au</a></div></li><li class="half_rhythm"><div><b>Leukodystrophy Foundation</b></div><div>1713, rue des &#x000c9;pinettes-Rouges</div><div>Qu&#x000e9;bec City Quebec G3G 2L2</div><div>Canada</div><div><b>Phone:</b> 418 806-2968</div><div><b>Fax:</b> 1 866 421-6846</div><div><b>Email:</b> info@leucofondation.com</div><div><a href="http://www.leukofoundation.com/en/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.leukofoundation.com</a></div></li><li class="half_rhythm"><div><b>United Leukodystrophy Foundation (ULF)</b></div><div>224 North Second Street</div><div>Suite 2</div><div>DeKalb IL 60115</div><div><b>Phone:</b> 800-728-5483 (toll-free); 815-748-3211</div><div><b>Fax:</b> 815-748-0844</div><div><b>Email:</b> office@ulf.org</div><div><a href="http://www.ulf.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ulf.org</a></div></li><li class="half_rhythm"><div><b>Myelin Disorders Bioregistry Project</b></div><div><b>Email:</b> myelindisorders@cnmc.org</div><div><a href="https://www.chop.edu/research/myelin-disorders-biorepository-project" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myelin Disorders Bioregistry Project</a></div></li></ul></div><div id="pol3-leuk.Molecular_Genetics"><h2 id="_pol3-leuk_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="pol3-leuk.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>POLR3-Related Leukodystrophy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK99167/table/pol3-leuk.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pol3-leuk.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_pol3-leuk.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_pol3-leuk.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_pol3-leuk.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_pol3-leuk.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_pol3-leuk.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_pol3-leuk.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9533" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>POLR1C</i></a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9533" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6p21<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O15160" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DNA-directed RNA polymerases I and III subunit RPAC1</a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/POLR1C" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">POLR1C @ LOVD</a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=POLR1C" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">POLR1C</a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=POLR1C[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">POLR1C</a></td></tr><tr><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/11128" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>POLR3A</i></a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=11128" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q22<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O14802" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DNA-directed RNA polymerase III subunit RPC1</a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/POLR3A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">POLR3A homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=POLR3A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">POLR3A</a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=POLR3A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">POLR3A</a></td></tr><tr><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/55703" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>POLR3B</i></a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=55703" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q23<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9NW08" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DNA-directed RNA polymerase III subunit RPC2</a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/POLR3B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">POLR3B @ LOVD</a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=POLR3B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">POLR3B</a></td><td headers="hd_b_pol3-leuk.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=POLR3B[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">POLR3B</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="pol3-leuk.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="pol3-leuk.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for POLR3-Related Leukodystrophy (<a href="/omim/607694,610060,614258,614366,614381,616494" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK99167/table/pol3-leuk.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pol3-leuk.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607694" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607694</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610060" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610060</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POLYMERASE I, RNA, SUBUNIT C; POLR1C</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614258" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614258</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POLYMERASE III, RNA, SUBUNIT A; POLR3A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614366" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614366</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POLYMERASE III, RNA, SUBUNIT B; POLR3B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614381" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614381</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616494" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616494</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11</td></tr></tbody></table></div></div><div id="pol3-leuk.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Three types of RNA polymerases (Pol I [POLR1], Pol II [POLR2], and Pol III [POLR3]) are responsible for the transcription of DNA into RNA [<a class="bk_pop" href="#pol3-leuk.REF.cramer.2008.337">Cramer et al 2008</a>, <a class="bk_pop" href="#pol3-leuk.REF.werner.2009.740">Werner et al 2009</a>]. POLR1, POLR2, and POLR3 have a distinct repertoire of DNA targets. POLR3A and POLR3B are the two largest subunits of POLR3 and form the catalytic core of the polymerase III. POLR1C is a shared subunit to POLR1 and POLR3.</p><ul><li class="half_rhythm"><div><b>POLR1</b> transcribes pre-rRNAs, which are modified into most of the ribosomal RNAs constituting the 18S, 5.8S, and 28S ribosomal subunits.</div></li><li class="half_rhythm"><div><b>POLR2</b> transcribes all protein-coding genes and multiple non-coding genes, including the majority of microRNAs (miRNAs).</div></li><li class="half_rhythm"><div><b>POLR3</b> has a diverse repertoire of nuclear targets and also transcribes exogenous DNA in the cytoplasm.</div><ul><li class="half_rhythm"><div>In the nucleus it transcribes all tRNAs (transfer RNAs), the RNA 7SL (which is necessary for the insertion of proteins into membranes), RNAs 7SK, Alu, and B2 elements (which are responsible for the regulation of the transcription of POLR2).</div></li><li class="half_rhythm"><div>POLR3 may play a role in the transcription of some miRNAs, but not to the same extent as POLR2 [<a class="bk_pop" href="#pol3-leuk.REF.dieci.2007.614">Dieci et al 2007</a>].</div></li><li class="half_rhythm"><div>POLR3 is responsible for the transcription of the ribosomal subunit 5S <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, which is involved in cytoplasmic and mitochondrial translation [<a class="bk_pop" href="#pol3-leuk.REF.szyma_ski.2003.641">Szyma&#x00144;ski et al 2003</a>].</div></li><li class="half_rhythm"><div>POLR3 transcribes vault RNAs, which become the vault organelles (responsible for the transport of the mRNAs from the nucleus to the cytoplasm).</div></li></ul></li></ul><div id="pol3-leuk.POLR3A"><h4><i>POLR3A</i></h4><p><b>Gene structure.</b>
<i>POLR3A</i> comprises 31 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK99167/#pol3-leuk.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Pathogenic variants include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants, small intragenic deletions, and insertions [<a class="bk_pop" href="#pol3-leuk.REF.bernard.2011.415">Bernard et al 2011</a>, <a class="bk_pop" href="#pol3-leuk.REF.saitsu.2011.644">Saitsu et al 2011</a>, <a class="bk_pop" href="#pol3-leuk.REF.potic.2012.920">Potic et al 2012</a>, <a class="bk_pop" href="#pol3-leuk.REF.daoud.2013.194">Daoud et al 2013</a>, <a class="bk_pop" href="#pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</a>, <a class="bk_pop" href="#pol3-leuk.REF.la_piana.2016.1622">La Piana et al 2016</a>]. See <a href="/books/NBK99167/bin/pol3-leuk-Tables3-5.pdf">Table 3</a> (pdf).</p><p>No <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has been found to have two <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> pathogenic variants, which may be explained by the role of <i>POLR3A</i> as a housekeeping <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, suggesting that some residual POLR3 function is essential for embryonic/fetal survival.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>POLR3A</i> encodes the DNA-directed RNA polymerase III subunit A (POLR3A) which comprises 1390 amino acids. POLR3A, the largest of the 17 subunits of POLR3, forms (together with POLR3B) the catalytic core of the polymerase.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mapping of the pathogenic variants to protein domains of POLR3A suggests that they can interfere with DNA binding directly, modify the catalytic cleft structure, change POLR3A/POLR3B interaction, and perturb interactions between POLR3A and other POLR3 subunits [<a class="bk_pop" href="#pol3-leuk.REF.bernard.2011.415">Bernard et al 2011</a>].</p><p>Western blot studies on fibroblasts and brain tissue from an individual with 4H leukodystrophy and known <i>POLR3A</i> pathogenic variants showed a statistically significant decrease in POLR3A levels, with a more significant reduction in the cerebral white matter compared to the cortex [<a class="bk_pop" href="#pol3-leuk.REF.bernard.2011.415">Bernard et al 2011</a>].</p><p>These later findings have led us to hypothesize that pathogenic variants in <i>POLR3A</i> lead to suboptimal assembly of the POLR3 complex, its <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> in the nucleus and/or interaction with chromatin. This hypothesis is supported by the results published on <i>POLR1C</i> leukodystrophy pathogenic variants.</p></div><div id="pol3-leuk.POLR3B"><h4><i>POLR3B</i></h4><p><b>Gene structure.</b>
<i>POLR3B</i> comprises 28 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK99167/#pol3-leuk.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Pathogenic variants include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants and small intragenic deletions [<a class="bk_pop" href="#pol3-leuk.REF.saitsu.2011.644">Saitsu et al 2011</a>, <a class="bk_pop" href="#pol3-leuk.REF.t_treault.2011.652">T&#x000e9;treault et al 2011</a>]. See <a href="/books/NBK99167/bin/pol3-leuk-Tables3-5.pdf">Table 4</a> (pdf). Recently, the first examples of large multiexon deletions have been reported [<a class="bk_pop" href="#pol3-leuk.REF.gutierrez.2015.69">Gutierrez et al 2015</a>].</p><p>No <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has been found to have two <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> pathogenic variants, which may be explained by the role of <i>POLR3B</i> as a housekeeping <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, suggesting that some residual POLR3 function is essential for embryonic/fetal survival.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>POLR3B</i> encodes the DNA-directed RNA polymerase III subunit B (POLR3B) which comprises 1133 amino acids. POLR3B, the second largest of the 17 subunits of POLR3, forms (together with POLR3A) the catalytic core of the polymerase.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mapping of the pathogenic variants to protein domains of POLR3B suggests that they can interfere with DNA binding directly, modify the catalytic cleft structure, change POLR3A/POLR3B interaction, and perturb interactions between POLR3B and other POLR3 subunits [<a class="bk_pop" href="#pol3-leuk.REF.t_treault.2011.652">T&#x000e9;treault et al 2011</a>].</p></div><div id="pol3-leuk.POLR1C"><h4><i>POLR1C</i></h4><p><b>Gene structure.</b>
<i>POLR1C</i> comprises nine exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK99167/#pol3-leuk.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Pathogenic leukodystrophy variants reported to date include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and small intragenic deletions different from the pathogenic variants known to cause <a href="/books/n/gene/tcs/">Treacher Collins syndrome</a>. See <a href="/books/NBK99167/bin/pol3-leuk-Tables3-5.pdf">Table 5</a> (pdf).</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>POLR1C</i> encodes the DNA-directed RNA polymerase I subunit C (POLR1C) which comprises 346 amino acids. POLR1C is a common subunit to both POLR1 and POLR3.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The abnormal &#x0201c;leukodystrophy&#x0201d; gene products p.Asn32Ile and p.Asn74Ser alter assembly and nuclear import of POLR3, but not POLR1, leading to decreased binding to POLR3 target genes, and not POLR1 target genes [<a class="bk_pop" href="#pol3-leuk.REF.thiffault.2015.7623">Thiffault et al 2015</a>].</p></div></div></div><div id="pol3-leuk.References"><h2 id="_pol3-leuk_References_">References</h2><div id="pol3-leuk.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.atrouni.2003.76">Atrouni S, Daraz&#x000e9; A, Tamraz J, Cassia A, Caillaud C, M&#x000e9;garban&#x000e9; A. Leukodystrophy associated with oligodontia in a large inbred family: fortuitous association or new entity? <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">118A</span>:76–81.</span> [<a href="/pubmed/12605447" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12605447</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.azmanov.2016.4302">Azmanov DN, Siira SJ, Chamova T, Kaprelyan A, Guergueltcheva V, Shearwood AJ, Liu G, Morar B, Rackham O, Bynevelt M, Grudkova M, Kamenov Z, Svechtarov V, Tournev I, Kalaydjieva L, Filipovska A. Transcriptome-wide effects of a POLR3A gene mutation in patients with an unusual phenotype of striatal involvement. <span><span class="ref-journal">Hum Mol Genet. </span>2016;<span class="ref-vol">25</span>:4302–14.</span> [<a href="/pubmed/27506977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27506977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.bekiesinskafigatowska.2010.574">Bekiesinska-Figatowska M, Mierzewska H, Kuczynska-Zardzewialy A, Szczepanik E, Obersztyn E. Hypomyelination, hypogonadotropic hypogonadism, hypodontia - First Polish patient. <span><span class="ref-journal">Brain Dev. </span>2010;<span class="ref-vol">32</span>:574–8.</span> [<a href="/pubmed/19700253" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19700253</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.bernard.2011.415">Bernard G, Chouery E, Putorti ML, T&#x000e9;treault M, Takanohashi A, Carosso G, Cl&#x000e9;ment I, Boespflug-Tanguy O, Rodriguez D, Delague V, Abou Ghoch J, Jalkh N, Dorboz I, Fribourg S, Teichmann M, Megarbane A, Schiffmann R, Vanderver A, Brais B. Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:415–23.</span> [<a href="/pmc/articles/PMC3169829/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3169829</span></a>] [<a href="/pubmed/21855841" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21855841</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.bernard.2010.457">Bernard G, Thiffault I, T&#x000e9;treault M, Putorti ML, Bouchard I, Sylvain M, Melancon S, Laframboise R, Langevin P, Bouchard JP, Vanasse M, Vanderver A, Sebire G, Brais B. Tremor-ataxia with central hypomyelination (TACH) leukodystrophy maps to chromosome 10q22.3-10q23.31. <span><span class="ref-journal">Neurogenetics. </span>2010;<span class="ref-vol">11</span>:457–64.</span> [<a href="/pmc/articles/PMC4147760/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4147760</span></a>] [<a href="/pubmed/20640464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20640464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.billington.2015.314594">Billington E, Bernard G, Gibson W, Corenblum B. Endrocrine aspects of 4H leukodystrophy: a case report and review of the literature. <span><span class="ref-journal">Case Rep Endocrinol. </span>2015;<span class="ref-vol">2015</span>:314594.</span> [<a href="/pmc/articles/PMC4465690/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4465690</span></a>] [<a href="/pubmed/26113998" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26113998</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.chouery.2011.73">Chouery E, Delague V, Jalkh N, Salem N, Kfoury J, Rodriguez D, Chabrol B, Boespflug-Tanguy O, L&#x000e9;vy N, Serre JL, M&#x000e9;garban&#x000e9; A. A whole-genome scan in a large family with leukodystrophy and oligodontia reveals linkage to 10q22. <span><span class="ref-journal">Neurogenetics. </span>2011;<span class="ref-vol">12</span>:73–8.</span> [<a href="/pubmed/20721593" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20721593</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.cramer.2008.337">Cramer P, Armache KJ, Baumli S, Benkert S, Brueckner F, Buchen C, Damsma GE, Dengl S, Geiger SR, Jasiak AJ, Jawhari A, Jennebach S, Kamenski T, Kettenberger H, Kuhn CD, Lehmann E, Leike K, Sydow JF, Vannini A. Structure of eukaryotic RNA polymerases. <span><span class="ref-journal">Annu Rev Biophys. </span>2008;<span class="ref-vol">37</span>:337–52.</span> [<a href="/pubmed/18573085" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18573085</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.daoud.2013.194">Daoud H, T&#x000e9;treault M, Gibson W, Guerrero K, Cohen A, Gburek-Augustat J, Synofzik M, Brais B, Stevens CA, Sanchez-Carpintero R, Goizet C, Naidu S, Vanderver A, Bernard G. Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism. <span><span class="ref-journal">J Med Genet. </span>2013;<span class="ref-vol">50</span>:194–7.</span> [<a href="/pubmed/23355746" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23355746</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.dieci.2007.614">Dieci G, Fiorino G, Castelnuovo M, Teichmann M, Pagano A. The expanding RNA polymerase III transcriptome. <span><span class="ref-journal">Trends Genet. </span>2007;<span class="ref-vol">23</span>:614–22.</span> [<a href="/pubmed/17977614" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17977614</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.gutierrez.2015.69">Gutierrez M, Thiffault I, Guerrero K, Martos-Moreno G, Tran L, Benko W, van der Knaap M, van Spaendonk R, Wolf N, Bernard G. Large exonic deletions in POLR3B gene cause POLR3-related leukodystrophy. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2015;<span class="ref-vol">10</span>:69.</span> [<a href="/pmc/articles/PMC4520020/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4520020</span></a>] [<a href="/pubmed/26045207" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26045207</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.jay.2016.3343">Jay AM, Conway RL, Thiffault I, Saunders C, Farrow E, Adams J, Toriello HV. Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170</span>:3343–6.</span> [<a href="/pubmed/27612211" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27612211</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.jurkiewicz.2017.213">Jurkiewicz E, Dunin-Wasowicz D, Gieruszczak-Bialek D, Malczyk K, Guerrero K, Gutierrez M, Tran L, Bernard G. Recessive mutations in POLR3B encoding RNA polymerase III subunit causing diffuse hypomyelination in patients with 4H leukodystrophy with polymicrogyria and cataracts. <span><span class="ref-journal">Clin Neuroradiol. </span>2017;<span class="ref-vol">27</span>:213–20.</span> [<a href="/pmc/articles/PMC5487884/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5487884</span></a>] [<a href="/pubmed/26478204" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26478204</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.la_piana.2016.1622">La Piana R, Cayami FK, Tran LT, Guerrero K, van Spaendonk R, Ounap K, Pajusalu S, Haack T, Wassmer E, Timmann D, Mierzewska H, Poll-The BT, Patel C, Cox H, Atik T, Onay H, Ozkinay F, Vanderver A, van der Knaap MS, Wolf NI, Bernard G. Diffuse hypomyelination is not obligate for POLR3-related disorders. <span><span class="ref-journal">Neurology. </span>2016;<span class="ref-vol">86</span>:1622–6.</span> [<a href="/pmc/articles/PMC4844237/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4844237</span></a>] [<a href="/pubmed/27029625" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27029625</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.la_piana.2014.214">La Piana R, Tonduti D, Gordish Dressman H, Schmidt JL, Murnick J, Brais B, Bernard G, Vanderver A. Brain magnetic resonance imaging (MRI) pattern recognition in Pol III-related leukodystrophies. <span><span class="ref-journal">J Child Neurol. </span>2014;<span class="ref-vol">29</span>:214–20.</span> [<a href="/pubmed/24105487" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24105487</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.orcesi.2010.359">Orcesi S, Tonduti D, Uggetti C, Larizza D, Fazzi E, Balottin U. New case of 4H syndrome and a review of the literature. <span><span class="ref-journal">Pediatr Neurol. </span>2010;<span class="ref-vol">42</span>:359–64.</span> [<a href="/pubmed/20399393" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20399393</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.potic.2012.920">Potic A, Brais B, Choquet K, Schiffmann R, Bernard G. 4H syndrome with late-onset growth hormone deficiency caused by POLR3A mutations. <span><span class="ref-journal">Arch Neurol. </span>2012;<span class="ref-vol">69</span>:920–3.</span> [<a href="/pubmed/22451160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22451160</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.potic.2015.22">Potic A, Popovic V, Ostojic J, Pekic S, Kozic D, Guerrero K, Schiffmann R, Bernard G. Neurogenic bladder and neuroendocrine abnormalities in Pol III-related leukodystrophy. <span><span class="ref-journal">BMC Neurol. </span>2015;<span class="ref-vol">15</span>:22.</span> [<a href="/pmc/articles/PMC4351912/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4351912</span></a>] [<a href="/pubmed/25868523" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25868523</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.saitsu.2011.644">Saitsu H, Osaka H, Sasaki M, Takanashi JI, Hamada K, Yamashita A, Shibayama H, Shiina M, Kondo Y, Nishiyama K, Tsurusaki Y, Miyake N, Doi H, Ogata K, Inoue K, Matsumoto N. Mutations in POLR3A and POLR3B encoding RNA polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:644–51.</span> [<a href="/pmc/articles/PMC3213392/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3213392</span></a>] [<a href="/pubmed/22036171" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22036171</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.sasaki.2009.582">Sasaki M, Takanashi J, Tada H, Sakuma H, Furushima W, Sato N. Diffuse cerebral hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum. <span><span class="ref-journal">Brain Dev. </span>2009;<span class="ref-vol">31</span>:582–7.</span> [<a href="/pubmed/18851904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18851904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.sato.2011.179">Sato I, Onuma A, Goto N, Sakai F, Fujiwara I, Uematsu M, Osaka H, Okahashi S, Nonaka I, Tanaka S, Haginoya K. A case with central and peripheral hypomyelination with hypogonadotropic hypogonadism and hypodontia (4H syndrome) plus cataract. <span><span class="ref-journal">J Neurol Sci. </span>2011;<span class="ref-vol">300</span>:179–81.</span> [<a href="/pubmed/20884016" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20884016</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.schiffmann.2009.750">Schiffmann R, van der Knaap MS. Invited article: an MRI-based approach to the diagnosis of white matter disorders. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">72</span>:750–9.</span> [<a href="/pmc/articles/PMC2677542/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2677542</span></a>] [<a href="/pubmed/19237705" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19237705</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.shimojima.2014.315">Shimojima K, Shimada S, Tamasaki A, Akaboshi S, Komoike Y, Saito A, Furukawa T, Yamamoto T. Novel compound heterozygous mutations of POLR3A revealed by whole-exome sequencing in a patient with hypomyelination. <span><span class="ref-journal">Brain Dev. </span>2014;<span class="ref-vol">36</span>:315–21.</span> [<a href="/pubmed/23694757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23694757</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.steenweg.2010.2971">Steenweg ME, Vanderver A, Blaser S, Bizzi A, de Koning TJ, Mancini GM, van Wieringen WN, Barkhof F, Wolf NI, van der Knaap MS. Magnetic resonance imaging pattern recognition in hypomyelinating disorders. <span><span class="ref-journal">Brain. </span>2010;<span class="ref-vol">133</span>:2971–82.</span> [<a href="/pmc/articles/PMC3589901/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3589901</span></a>] [<a href="/pubmed/20881161" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20881161</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.szyma_ski.2003.641">Szyma&#x00144;ski M, Barciszewska MZ, Erdmann VA, Barciszewski J. 5 S rRNA: structure and interactions. <span><span class="ref-journal">Biochem J. </span>2003;<span class="ref-vol">371</span>:641–51.</span> [<a href="/pmc/articles/PMC1223345/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1223345</span></a>] [<a href="/pubmed/12564956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12564956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.takanashi.2014.259">Takanashi J, Osaka H, Saitsu H, Sasaki M, Mori H, Shibayama H, Tanaka M, Nomura Y, Terao Y, Inoue K, Matsumoto N, Barkovich AJ. Different patterns of cerebellar abnormality and hypomyelination between POLR3A and POLR3B mutations. <span><span class="ref-journal">Brain Dev. </span>2014;<span class="ref-vol">36</span>:259–63.</span> [<a href="/pubmed/23643445" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23643445</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.t_treault.2011.652">T&#x000e9;treault M, Choquet K, Orcesi S, Tonduti D, Balottin U, Teichmann M, Fribourg S, Schiffmann R, Brais B, Vanderver A, Bernard G. Recessive mutations in POLR3B, encoding the second largest subunit of Pol III, cause a rare hypomyelinating leukodystrophy. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:652–5.</span> [<a href="/pmc/articles/PMC3213403/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3213403</span></a>] [<a href="/pubmed/22036172" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22036172</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.t_treault.2012.122">T&#x000e9;treault M, Putorti ML, Thiffault I, Sylvain M, Venderver A, Schiffmann R, Brais B, Bernard G. TACH leukodystrophy: locus refinement to chromosome 10q22.3-23.1. <span><span class="ref-journal">Can J Neurol Sci. </span>2012;<span class="ref-vol">39</span>:122–3.</span> [<a href="/pubmed/22384513" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22384513</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.thiffault.2015.7623">Thiffault I, Wolf NI, Forget D, Guerrero K, Tran LT, Choquet K, Lavallee-Adam M, Poitras C, Brais B, Yoon G, Sztriha L, Webster RI, Timmann D, van de Warrenburg BP, Seeger J, Zimmermann A, Mate A, Goizet C, Fung E, van der Knaap MS, Fribourg S, Vanderver A, Simons C, Taft RJ, Yates III JR, Coulombe B, Bernard G. Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III. <span><span class="ref-journal">Nat Commun. </span>2015;<span class="ref-vol">6</span>:7623–31.</span> [<a href="/pmc/articles/PMC4506509/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4506509</span></a>] [<a href="/pubmed/26151409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26151409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.timmons.2006.2066">Timmons M, Tsokos M, Asab MA, Seminara SB, Zirzow GC, Kaneski CR, Heiss JD, van der Knaap MS, Vanier MT, Schiffmann R, Wong K. Peripheral and central hypomyelination with hypogonadotropic hypogonadism and hypodontia. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:2066–9.</span> [<a href="/pmc/articles/PMC1950601/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1950601</span></a>] [<a href="/pubmed/17159124" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17159124</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.v_zquezl_pez.2008.204">V&#x000e1;zquez-L&#x000f3;pez M, Ruiz-Mart&#x000ed;n Y, de Castro-Castro P, Garzo-Fern&#x000e1;ndez C, Mart&#x000ed;n-del Valle F, M&#x000e1;rquez-de la Plata L. <span><span class="ref-journal">Rev Neurol. </span>2008;<span class="ref-vol">47</span>:204–8.</span> [Central hypomyelination, hypogonadotrophic hypogonadism and hypodontia: a new leukodystrophy] [<a href="/pubmed/18671210" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18671210</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.werner.2009.740">Werner M, Thuriaux P, Soutourina J. Structure-function analysis of RNA polymerases I and III. <span><span class="ref-journal">Curr Opin Struct Biol. </span>2009;<span class="ref-vol">19</span>:740–5.</span> [<a href="/pubmed/19896367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19896367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.wolf.2005.1461">Wolf NI, Harting I, Boltshauser E, Wiegand G, Koch MJ, Schmitt-Mechelke T, Martin E, Zschocke J, Uhlenberg B, Hoffmann GF, Weber L, Ebinger F, Rating D. Leukoencephalopathy with ataxia, hypodontia, and hypomyelination. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:1461–4.</span> [<a href="/pubmed/15851747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15851747</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.wolf.2007.64">Wolf NI, Harting I, Innes AM, Patzer S, Zeitler P, Schneider A, Wolff A, Baier K, Zschocke J, Ebinger F, Boltshauser E, Rating D. Ataxia, delayed dentition and hypomyelination: a novel leukoencephalopathy. <span><span class="ref-journal">Neuropediatrics. </span>2007;<span class="ref-vol">38</span>:64–70.</span> [<a href="/pubmed/17712733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17712733</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.wolf.2014.1898">Wolf NI, Vanderver A, van Spaendonk RM, Schiffmann R, Brais B, Bugiani M, Sistermans E, Catsman-Berrevoets C, Kros JM, Pinto PS, Pohl D, Tirupathi S, Stromme P, de Grauw T, Fribourg S, Demos M, Pizzino A, Naidu S, Guerrero K, van der Knaap MS, Bernard G. 4H Research Group. Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">83</span>:1898–905.</span> [<a href="/pmc/articles/PMC4248461/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4248461</span></a>] [<a href="/pubmed/25339210" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25339210</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.wolff.2010.386">Wolff A, Koch MJ, Benzinger S, van Waes H, Wolf NI, Boltshauser E, Luder HU. Rare dental peculiarities associated with the hypomyelinating leukoencephalopathy 4H syndrome/ADDH. <span><span class="ref-journal">Pediatr Dent. </span>2010;<span class="ref-vol">32</span>:386–92.</span> [<a href="/pubmed/21070704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21070704</span></a>]</div></li></ul></div><div id="pol3-leuk.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="pol3-leuk.REF.van_haren.2015.516">Van Haren K, Bonkowsky JL, Bernard G, Murphy JL, Pizzino A, Helman G, Suhr D, Waggoner J, Hobson D, Vanderver A, Patterson MC, et al.  Consensus statement on preventive and symptomatic care of leukodystrophy patients. <span><span class="ref-journal">Mol Genet Metab. </span>2015;<span class="ref-vol">114</span>:516–26.</span> [<a href="/pubmed/25577286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25577286</span></a>]</div></li></ul></div></div><div id="pol3-leuk.Chapter_Notes"><h2 id="_pol3-leuk_Chapter_Notes_">Chapter Notes</h2><div id="pol3-leuk.Author_Notes"><h3>Author Notes</h3><p>Contact information for Dr. Genevi&#x000e8;ve Bernard&#x02019;s laboratory at the Research Institute of the McGill University Health Centre:</p><p><b>Pediatric Neurodegenerative Laboratory</b><br />1001 boul D&#x000e9;carie<br />Site Glen Pavilion E / Block E<br />CHHD Mail Drop Point #EM03211 (cubicle C )<br />Montr&#x000e9;al, QC H4A 3J1<br />Canada</p><p><a href="mailto:dev@null" data-email="ac.lligcm@dranreb.eveiveneG" class="oemail">ac.lligcm@dranreb.eveiveneG</a></p><p>514-934-1934 ext. 23380</p></div><div id="pol3-leuk.Acknowledgments"><h3>Acknowledgments</h3><p>Drs. Bernard and Vanderver wish to thank all patients and their families as well as all the collaborators who are involved in the POLR3-related leukodystrophy project. Dr. Bernard has received a Research Scholar Junior 1 award from the Fonds de Recherche du Qu&#x000e9;bec en Sant&#x000e9; (FRQS) 2012-2016 and a Canadian Institute of Health Research New Investigator salary award (2017-2022) (201512MSH-360766-171036). She wishes to thank the Canadian Institutes of Health Research (CIHR MOP-G-287547 and MOP-G2-341146-159133-BRIDG), the R&#x000e9;seau de M&#x000e9;decine G&#x000e9;n&#x000e9;tique Appliqu&#x000e9;e (RMGA), the Leuko Dystrophy Foundation, the "Fondation du Grand D&#x000e9;fi Pierre Lavoie," the European Leukodystrophy Association, and the "Fondation les Amis D'Elliot," for financing her research projects on leukodystrophies. Dr. Vanderver wishes to thank the Intramural Research Program of the National Human Genome Research Institute and the Myelin Disorders Bioregistry Project.</p></div><div id="pol3-leuk.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>11 May 2017 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>2 August 2012 (me) Review posted live</div></li><li class="half_rhythm"><div>1 March 2012 (av) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK99167</span><span class="label">PMID: <a href="/pubmed/22855961" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">22855961</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/alpers/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ppp2r5d-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK99167&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK99167/?report=reader">PubReader</a></li><li><a href="/books/NBK99167/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK99167" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK99167" style="display:none" title="Cite this Page"><div class="bk_tt">Bernard G, Vanderver A. POLR3-Related Leukodystrophy. 2012 Aug 2 [Updated 2017 May 11]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK99167/pdf/Bookshelf_NBK99167.pdf">PDF version of this page</a> (534K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#pol3-leuk.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#pol3-leuk.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#pol3-leuk.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#pol3-leuk.Genetically_Related_Allelic_Di" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#pol3-leuk.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#pol3-leuk.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#pol3-leuk.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#pol3-leuk.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#pol3-leuk.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#pol3-leuk.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#pol3-leuk.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55703[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">POLR3B</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9533[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">POLR1C</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=11128[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">POLR3A</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK99167+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2963930" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2963930" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2963930" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2963930" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31438894" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Novel mutations of the POLR3A gene caused POLR3-related leukodystrophy in a Chinese family: a case report.</a><span class="source">[BMC Pediatr. 2019]</span><div class="brieflinkpop offscreen_noflow">Novel mutations of the POLR3A gene caused POLR3-related leukodystrophy in a Chinese family: a case report.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wu S, Bai Z, Dong X, Yang D, Chen H, Hua J, Zhou L, Lv H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Pediatr. 2019 Aug 22; 19(1):289. Epub 2019 Aug 22.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24501781" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leukodystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leukodystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Vanderver A, Tonduti D, Schiffmann R, Schmidt J, van der Knaap MS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29618326" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A novel homozygous mutation in POLR3A gene causing 4H syndrome: a case report.</a><span class="source">[BMC Pediatr. 2018]</span><div class="brieflinkpop offscreen_noflow">A novel homozygous mutation in POLR3A gene causing 4H syndrome: a case report.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tewari VV, Mehta R, Sreedhar CM, Tewari K, Mohammad A, Gupta N, Gulati S, Kabra M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Pediatr. 2018 Apr 4; 18(1):126. Epub 2018 Apr 4.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26151409" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III.</a><span class="source">[Nat Commun. 2015]</span><div class="brieflinkpop offscreen_noflow">Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Thiffault I, Wolf NI, Forget D, Guerrero K, Tran LT, Choquet K, Lavallée-Adam M, Poitras C, Brais B, Yoon G, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Nat Commun. 2015 Jul 7; 6:7623. Epub 2015 Jul 7.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=22855961" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=22855961" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc93bcdde0891169c302b9">POLR3-Related Leukodystrophy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">POLR3-Related Leukodystrophy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:26:20-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BA2BEDFC886E100000000059A0274&amp;ncbi_session=CE8BA2BEDFC93BC1_1434SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK99167%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK99167&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK99167/&amp;ncbi_pagename=POLR3-Related Leukodystrophy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BA2BEDFC93BC1_1434SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>